PT  - JOURNAL ARTICLE
AU  - Xiaoying Zhao
AU  - Guoli Hu
AU  - Chuandong Wang
AU  - Lei Jiang
AU  - Jingyu Zhao
AU  - Jiake Xu
AU  - Xiaoling Zhang
TI  - PIP5k1 β controls bone homeostasis through modulating both osteoclast and osteoblast differentiation
AID  - 10.1101/288910
DP  - 2018 Jan 01
TA  - bioRxiv
PG  - 288910
4099  - http://biorxiv.org/content/early/2018/03/26/288910.short
4100  - http://biorxiv.org/content/early/2018/03/26/288910.full
AB  - PIP5K1β is crucial to generation of phosphotidylinosotol (4, 5) P2. PIP5K1β participates in numerous cellular activities, such as B cell and platelet activation, cell phagocytosis and endocytosis, cell apoptosis, and cytoskeletal organization. In the present work, we aimed to make insight into the function of PIP5K1β in osteoclastogenesis and osteogenesis to provide promising strategies for osteoporosis prevention and treatment. We discovered that PIP5k1β deletion in mice resulted in obvious bone loss and PIP5K1β was highly expressed both during osteoclast and osteoblast differentiation, besides, PIP5K1β deletion enhanced the proliferation and migration of BMMs to promote osteoclast differentiation. PIP5k1β−/− osteoclast exhibited normal cytoskeleton architecture but stronger resorption activity. PIP5k1β deficiency also promoted activation of MAPK and Akt signaling, enhanced TRAF6 and c-Fos expression, facilitated the expression and nuclear translocation of NFATC1 and upregulated Grb2 expression, thereby accelerating osteoclast differentiation and function. Finally, PIP5K1β enhanced osteoblast differentiation by upregulating master genes expression through triggering smad1/5/8 signaling. Thereby, PIP5K1β modulate bone homeostasis and remodeling.